Glutamate is the primary excitatory neurotransmitter in the vertebrate CNS, acting through AMPA and NMDA receptors to depolarize postsynaptic neurons. While essential for information transfer and learning, glutamate overexcitation causes excitotoxicity and neuronal damage, implicating it in neurodegenerative diseases.
From your study of synaptic transmission, you know that neurotransmitters released from presynaptic terminals bind postsynaptic receptors to generate excitatory or inhibitory potentials. Glutamate is by far the most abundant excitatory neurotransmitter in the vertebrate central nervous system — roughly 80% of all synapses in the cortex are glutamatergic. Virtually every sensory perception, motor command, and cognitive process you experience depends on glutamate-driven excitation as its fundamental signaling currency.
Glutamate acts through two major classes of ionotropic receptors, and understanding their distinct properties is essential. AMPA receptors (named after their synthetic agonist α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) are the workhorses of fast excitatory transmission. When glutamate binds, AMPA receptors open rapidly and allow sodium ions to flow into the postsynaptic neuron, producing a quick excitatory postsynaptic potential (EPSP) that depolarizes the cell. These receptors open and close within milliseconds, making them ideal for point-to-point information transfer. NMDA receptors (N-methyl-D-aspartate receptors) are more complex. They require both glutamate binding *and* postsynaptic depolarization to open, because at resting membrane potential a magnesium ion physically blocks the channel pore. Only when the postsynaptic membrane is already partially depolarized — typically by nearby AMPA receptor activation — does the Mg²⁺ block get relieved, allowing the NMDA channel to conduct. This dual requirement makes the NMDA receptor a coincidence detector: it opens only when the presynaptic neuron releases glutamate *and* the postsynaptic neuron is simultaneously active.
This coincidence-detection property is the molecular basis of synaptic plasticity — the ability of synapses to strengthen or weaken with experience. When NMDA receptors open, they admit calcium ions in addition to sodium. The resulting calcium influx triggers intracellular signaling cascades that can insert more AMPA receptors into the postsynaptic membrane, making the synapse permanently more responsive to future glutamate release. This process, called long-term potentiation (LTP), is widely considered the cellular mechanism underlying learning and memory. The NMDA receptor's requirement for coincident pre- and postsynaptic activity implements a biological version of Hebb's rule: "neurons that fire together wire together."
However, glutamate's power comes with a dangerous flip side. Because glutamate drives calcium entry through NMDA receptors, excessive glutamate release can flood neurons with toxic levels of calcium — a process called excitotoxicity. The calcium overload activates destructive enzymes (proteases, lipases, endonucleases), generates free radicals, and triggers apoptotic pathways, ultimately killing the neuron. Excitotoxicity plays a central role in neuronal death during stroke (where oxygen deprivation causes uncontrolled glutamate release), traumatic brain injury, and neurodegenerative diseases including Alzheimer's, Parkinson's, and ALS. The drug memantine, used in Alzheimer's treatment, works by partially blocking NMDA receptors to reduce excitotoxic calcium entry while still allowing normal synaptic signaling. The brain's challenge is maintaining glutamate signaling at levels sufficient for information processing and plasticity without tipping into the destructive excess that kills the very neurons it activates.